Pharmacologic strategies may be able to prevent abnormal uterine bleeding in patients undergoing stem cell transplant.

The PDUFA dates have been pushed for sotorasib and obeticholic acid for metastatic colorectal cancer and primary biliary ...

Treatment effectiveness can have different meanings to patients,” a physician assistant said when discussing therapy for high ...

Patients with breast cancer who are of childbearing age may face issues that are accentuated by their age, an expert ...

A nurse practitioner discussed considerations for managing aromatase inhibitor-related joint pain in patients with breast ...

As biomarkers continue to be explored in resectable melanoma, oncology nurses will play a crucial role in the clinical trial ...

A poll of experts revealed that few are utilizing talquetamab for patients with pretreated relapsed/refractory myeloma.

Extensive-stage (stage IV) SCLC, on the other hand, is a disease that has spread outside the bounds of 1 radiation field, and ...

After a patient with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer experiences disease progression ...

An expert explained the role oncology nurses and advanced practice providers play in caring for patients with sarcoma during treatment.

Inavolisib plus palbociclib and fulvestrant was approved for the treatment of PIK3CA-mutant, HR-positive, HER2-negative locally advanced or metastatic breast cancer. The FDA approved inavolisib ...